Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy. Berte' R, Mazza S, Stefanucci MR, Noviello D, et al. J Crohns Colitis 2021;15:864-868.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Berte' R, Mazza S, Stefanucci MR, Noviello D, et al. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy. J Crohns Colitis 2021;15:864-868.
PMID: 33211810